Back to Results
First PageMeta Content
Glycogen storage disease type II / Newborn screening / Lysosomal storage disease / Screening / Severe combined immunodeficiency / Adrenoleukodystrophy / Spinal muscular atrophy / Health / Rare diseases / Medicine


FOR IMMEDIATE RELEASE May 17, 2013 Contact: Natasha Bonhomme[removed]x211 [removed]
Add to Reading List

Document Date: 2014-03-24 17:53:59

Open Document

File Size: 88,07 KB

Share Result on Facebook

City

WASHINGTON / /

Company

Genzyme / /

/

Facility

University of Washington / /

IndustryTerm

Treatment for Pompe disease / treatment protocol / healthcare / smart services / /

MedicalCondition

lysosomal storage disorder / Severe Combined Immunodeficiency / Spinal Muscular Atrophy / Krabbe Disease / late onset disease / Recommends Pompe Disease / alpha-L-idurinidase deficiency / Niemann-Pick Disease / Critical Congenital Heart Disease / Deletion Syndrome / Critical Congenital Heat Disease / Fabry Disease / Adrenoleukodystrophy / heritable Disorders / SCID / illness / Neonatal Hyperbilirubinemia / MS / Pompe Disease / heritable disorder / /

MedicalTreatment

treatment protocol / enzyme replacement therapy / /

Organization

University of Washington / U.S. Department of Health and Human Services / Congress / Genetic Alliance / Genetic Alliance Genetic Alliance / Discretionary Advisory Committee for Heritable Disorders / Advisory Committee / /

Person

Natasha F. Bonhomme / Natasha Bonhomme / /

/

Position

Secretary of Health / Secretary of Health and Human Services / vice president of strategic development and director / Secretary / /

ProvinceOrState

Missouri / /

Technology

alpha / treatment protocol / genotyping / /

URL

http /

SocialTag